BCAT (BlackRock Capital Allocation Term Trust) Expects $43 Million From Rights Offering

View the BCAT Dividend Stock Profile

BlackRock Capital Allocation Term Trust announced on October 21, 2026 that its rights offering had expired, with approximately $43 million of proceeds anticipated. The fund expects to issue about 3.3 million common shares at $13.30 each, giving its managers more money to invest while slightly reducing the asset value behind each existing share.

The final subscription price equals 98.5% of the fund’s net asset value, or NAV, on October 21. NAV is the value of the investments and other assets remaining after liabilities, divided by the shares outstanding. Issuing new shares below that value dilutes NAV per share because each new share brings in less than its share of the existing assets.

There is a useful offset: BlackRock Advisors has agreed to pay all offering expenses, so those costs will not take another bite out of the fund’s proceeds. The expected share count also includes subscriptions made through notices of guaranteed delivery, meaning the announced proceeds and issuance remain approximate. They should not be read as final settled amounts.

The offer allowed subscriptions for up to 21.3 million shares, substantially more than the approximately 3.3 million now expected. That makes the announced capital increase much smaller than the maximum contemplated in the prospectus. It does not remove the below-NAV issuance cost, and the announcement does not quantify the final change in NAV per share.

BCAT seeks income and total return through investments that can include shares and debt securities, as well as an option-writing strategy. Its managers intend to invest the new money under the existing objectives and policies. More invested capital can produce more income in dollars, but the larger share count also spreads that income across more claims on the fund. The important result for an existing shareholder is what the investments earn per share after costs, alongside how much capital remains behind the distribution.

Our view is that paying the offering expenses is a welcome protection, but issuing shares below NAV still asks existing shareholders to accept a cost today for investment results that have yet to arrive. We would become more positive if subsequent reports show improved income and investment results per share sufficient to support distributions while preserving capital. The $43 million itself is new shareholder money, not evidence that the fund has earned its payments.

Sources

• BlackRock’s October 21, 2026 rights-offering results announcement (company announcement reproduced by MarketScreener)
• BCAT’s rights-offering prospectus supplement, including pricing, expenses and dilution

This article is general information, not personalized investment advice. Fly High Investing may hold securities discussed in this article.